Bocom initiated coverage of Bristol Myers with a Sell rating and $33.10 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers price target lowered to $43 from $47 at UBS
- Truist biotech analyst holds an analyst/industry conference call
- Bristol Myers price target lowered to $41 from $43 at Barclays
- VYNE Therapeutics announces appointment of Banerjee as SVP
- Ex-Dividend Date Nearing for These 10 Stocks – Week of July 1, 2024